The Radiotherapy Market is projected to reach US$ 10,170.80 million by 2028 from US$ 6,474.78 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028.
Radiotherapy is majorly used to control the growth of the tumor and with the minimum exposure to the surrounding normal and healthy tissue. Radiotherapy uses high-energy radiation, generally x-rays, to destroy the cancer cells and treat tumors in the prostate, breast, head & neck, lung and at any other parts in the body where radiation treatment is indicated. Advances in radiotherapy have been made in the last few years, as improvements in imaging modalities, powerful computers and software and delivery systems have enabled technologies.
The radiotherapy market is expected to witness substantial growth after the pandemic. Delayed or rescheduled radiation therapy treatments and new cases of cancer are anticipated to have positive impact on the radiotherapy market growth post-pandemic. In addition, several number of research centers and governments are actively engaged in the conducting seminars and symposiums to spread awareness about benefits of radiotherapy. These factors will eventually drive the market growth.
Get Sample PDF:
https://www.theinsightpartners.com/sample/TIPMD00002668/
Radiotherapy is majorly used to control the growth of a tumor while restricting the harm to nearby normal and healthy tissue. Radiotherapy uses high-energy radiation, generally x-rays, to destroy the cancer cells and treat tumors in the prostate, breast, head & neck, lung, and any other parts in the body where radiation treatment is indicated.
Based on application, the radiotherapy market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer, liver cancer, thyroid cancer, lymphoma, spine cancer, brain cancer, and others. In 2020, the breast cancer segment held the largest share of the market. However, the lung cancer segment is estimated to register the highest CAGR of 7.5% during the forecast period.
Buy Now: https://www.theinsightpartners.com/buy/TIPMD00002668/
The report segments radiotherapy market as follows:
By Type
• External-Beam Radiation Therapy
• Internal Radiation Therapy
• Systemic Radiotherapy/Radiopharmaceuticals
By Product
• External Beam Radiotherapy Products
• Internal Radiotherapy Products
• Radiotherapy Software
• Others
By Application
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Cervical Cancer
• Liver Cancer
• Thyroid Cancer
• Lymphoma
• Spine Cancer
• Brain Cancer
• Others
By End User
• Hospitals
• Specialty Clinics
• Radiation Therapy Centers
By Geography
• North America
US
Canada
Mexico
• Europe
France
Germany
UK
Spain
Italy
Rest of Europe
• Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of APAC
• Middle East & Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of MEA
• South and Central America (SCAM)
Brazil
Argentina
Rest of SCAM
List of Companies
1. Siemens Healthineers AG
2. Accuray Incorporated
3. Sumitomo Heavy Industries, Ltd.
4. Elekta AB
5. Hitachi, Ltd.
6. Koninklijke Philips N.V.
7. Brainlab AG
8. PROTOM INTERNATIONAL
9. Varian Medical Systems, Inc.
10. Maastro
11. Mevion Medical Systems
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
